Fluticasone prop HFA 110 MCG 12GM
Ended Awarded
- Contract number
- SPE2DB25FNUUY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,169
Award facts
- Contract value 100% obligated
- $2,169.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,169.18 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalant medication (12 gram units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, vials, and medical test kits across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a primary vendor in the DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DB25FNUUY?
SPE2DB25FNUUY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FNUUY worth?
The government has obligated $2,169 on SPE2DB25FNUUY.
Is contract SPE2DB25FNUUY an order under another contract?
Yes. SPE2DB25FNUUY is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNUUY competed?
The extent of competition for SPE2DB25FNUUY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award